Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02073578 · ClinicalTrials.gov registry record · NA

Peroral Endoscopic Myotomy (POEM) for the Treatment of Achalasia

A NA study of Achalasia, sponsored by Ohio State University.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT02073578 is a NA study of Achalasia that has completed, run by Ohio State University. The registered enrollment target is 20 participants, below the 139-participant average among 7 other Achalasia trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02073578, a NA study of Achalasia, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This is a pilot study for a new endoscopic treatment of achalasia. Up to 25 patients will be recruited for this trial, with the intent to treat 20 patients.

Conditions Studied

Achalasia

Interventions

  • PROCEDURE Peroral Endoscopic Myotomy (POEM)

Study Locations (1)

Ohio

  • The Ohio State University Wexner Medical Center - Columbus

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2012-08
Est. Completion 2014-12
Phase NA

Sponsor

Ohio State University

552 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02073578

The ClinicalTrials.gov registry entry for NCT02073578 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 139-participant average among 7 other Achalasia trials with a reported enrollment target (86% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Achalasia appearing as the primary indexed condition, and to 1 intervention - of which Peroral Endoscopic Myotomy (POEM) is the first listed.

NCT02073578 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT02073578 about?

NCT02073578 is a clinical study titled "Peroral Endoscopic Myotomy (POEM) for the Treatment of Achalasia". This is a pilot study for a new endoscopic treatment of achalasia. Up to 25 patients will be recruited for this trial, with the intent to treat 20 patients.

What is the current status of trial NCT02073578?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2012-08. Estimated completion is 2014-12.

What conditions does trial NCT02073578 study?

This clinical trial studies the following conditions: Achalasia.

What interventions are being tested in trial NCT02073578?

The interventions under investigation include: Peroral Endoscopic Myotomy (POEM) (PROCEDURE).

Who is sponsoring clinical trial NCT02073578?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02073578 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Achalasia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Achalasia

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.